Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $99.8B |
| FY2017, ended Dec 31, 2017 | $154B |
| FY2018, ended Dec 31, 2018 | $136B |
| FY2019, ended Dec 31, 2019 | $131B |
| FY2020, ended Dec 31, 2020 | $189B |
| FY2021, ended Dec 31, 2021 | $239B |
| FY2022, ended Dec 31, 2022 | $286B |
| FY2023, ended Dec 31, 2023 | $274B |
| FY2024, ended Dec 31, 2024 | $314B |
| FY2025, ended Dec 31, 2025 | $404B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $445B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $25.6B |
| FY2017, ended Dec 31, 2017 | $28.2B |
| FY2018, ended Dec 31, 2018 | $32.8B |
| FY2019, ended Dec 31, 2019 | $33.3B |
| FY2020, ended Dec 31, 2020 | $45.8B |
| FY2021, ended Dec 31, 2021 | $56.2B |
| FY2022, ended Dec 31, 2022 | $58.1B |
| FY2023, ended Dec 31, 2023 | $54.3B |
| FY2024, ended Dec 31, 2024 | $56.3B |
| FY2025, ended Dec 31, 2025 | $61.2B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $64.4B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $5.95B | $6.56B |
| FY2017, ended Dec 31, 2017 | $5.31B | $9.43B |
| FY2018, ended Dec 31, 2018 | $5.69B | $12.8B |
| FY2019, ended Dec 31, 2019 | $7.88B | $12.8B |
| FY2020, ended Dec 31, 2020 | $4.62B | $16.8B |
| FY2021, ended Dec 31, 2021 | $11.5B | $22.0B |
| FY2022, ended Dec 31, 2022 | $11.8B | $24.2B |
| FY2023, ended Dec 31, 2023 | $4.86B | $22.1B |
| FY2024, ended Dec 31, 2024 | $4.28B | $17.8B |
| FY2025, ended Dec 31, 2025 | $4.23B | $17.8B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $6.31B | $18.2B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $5.10B |
| FY2017, ended Dec 31, 2017 | $9.30B |
| FY2018, ended Dec 31, 2018 | $7.29B |
| FY2019, ended Dec 31, 2019 | $39.9B |
| FY2020, ended Dec 31, 2020 | $8.45B |
| FY2021, ended Dec 31, 2021 | $9.75B |
| FY2022, ended Dec 31, 2022 | $9.20B |
| FY2023, ended Dec 31, 2023 | $12.8B |
| FY2024, ended Dec 31, 2024 | $5.52B |
| FY2025, ended Dec 31, 2025 | $5.23B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $6.57B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $36.8B |
| FY2017, ended Dec 31, 2017 | $37.4B |
| FY2018, ended Dec 31, 2018 | $40.3B |
| FY2019, ended Dec 31, 2019 | $67.2B |
| FY2020, ended Dec 31, 2020 | $85.0B |
| FY2021, ended Dec 31, 2021 | $76.0B |
| FY2022, ended Dec 31, 2022 | $63.1B |
| FY2023, ended Dec 31, 2023 | $59.2B |
| FY2024, ended Dec 31, 2024 | $66.8B |
| FY2025, ended Dec 31, 2025 | $67.0B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $70.8B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 10.9% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.59B |
| FY2017, ended Dec 31, 2017 | 1.59B |
| FY2018, ended Dec 31, 2018 | 1.48B |
| FY2019, ended Dec 31, 2019 | 1.48B |
| FY2020, ended Dec 31, 2020 | 1.77B |
| FY2021, ended Dec 31, 2021 | 1.77B |
| FY2022, ended Dec 31, 2022 | 1.77B |
| FY2023, ended Dec 31, 2023 | 1.77B |
| FY2024, ended Dec 31, 2024 | 1.77B |
| FY2025, ended Dec 31, 2025 | 1.77B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 1.77B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $6.03B | $353M | $3.92B |
| FY2017, ended Dec 31, 2017 | $1.41B | $365M | — |
| FY2018, ended Dec 31, 2018 | $12.0B | $421M | — |
| FY2019, ended Dec 31, 2019 | $629M | $430M | — |
| FY2020, ended Dec 31, 2020 | $978M | $753M | $24.4B |
| FY2021, ended Dec 31, 2021 | $934M | $692M | — |
| FY2022, ended Dec 31, 2022 | $1.49B | $671M | — |
| FY2023, ended Dec 31, 2023 | $1.97B | $747M | — |
| FY2024, ended Dec 31, 2024 | $1.71B | $911M | — |
| FY2025, ended Dec 31, 2025 | $980M | $955M | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.50B | $976M | — |
Valuation
At current price- Market Cap
- $506B
- P/E
- 80.2×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 7.9×
- Price / Book
- n/m. Market cap / shareholders' equity
- EV / EBITDA
- 23.1×
Growth
Trailing 12 months- Revenue (TTM)
- $64.4B
- Revenue Growth YoY
- 10.4%
- Revenue CAGR 3Y
- 1.8%
- Revenue CAGR 5Y
- 6.0%
- EPS Growth YoY
- 68.6%
- Net Income Growth YoY
- 67.7%
Profitability
Trailing 12 months- Gross Margin
- 71.5%
- Operating Margin
- 26.2%
- Net Margin
- 9.8%
- FCF Margin
- 28.3%
- Return on Equity
- n/m. Net income (TTM) / average equity
Earnings
Trailing 12 months- Net Income
- $6.31B
- EPS (diluted)
- $3.54
- EBITDA
- $24.7B
- Operating Income
- $16.9B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $6.57B
- Total Debt
- $70.8B
- Net Debt
- $64.3B
- Total Assets
- $135B
- Total Liabilities
- $141B
- Shareholders' Equity
- −$5.93B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $19.5B
- Capital Expenditure
- $1.30B
- Free Cash Flow
- $18.2B
Dividends and risk
Last 12 months- Dividend Yield
- 2.4%
- Dividend / Share
- $6.92
- Beta (5Y)
- 0.24
Every ratio is calculated from the company’s reported figures.